Table 3.
Mean Serum Antibody of Humans Before and After Inactivated Influenza Vaccine With or Without Alpha Interfeon1
Vaccine Virus and Assay1 |
Interferon Group3 (N) |
||
---|---|---|---|
0 (32) |
1M (32) |
10M (31) |
|
H1 | |||
HAI Pre4 | 3.56 | 4.41 | 4.19 |
2 wks | 6.00 | 6.22 | 5.48 |
4 wks | 6.06 | 6.22 | 5.61 |
Neut Pre | 3.66 | 4.22 | 4.19 |
2 wks | 5.56 | 5.78 | 5.44 |
4 wks | 5.84 | 6.23 | 5.69 |
H3 | |||
HAI Pre4 | 3.78 | 3.81 | 4.68 |
2 wks | 5.84 | 5.25 | 5.58 |
4 wks | 5.97 | 5.66 | 5.74 |
Neut Pre | 5.25 | 5.20 | 6.40 |
2 wks | 7.38 | 6.78 | 7.61 |
4 wks | 7.61 | 6.59 | 7.44 |
B | |||
HAI Pre4 | 2.75 | 3.16 | 3.19 |
2 wks | 3.97 | 4.50 | 4.00 |
4 wks | 4.28 | 4.78 | 4.32 |
Neut Pre | 2.50 | 3.41 | 3.02 |
2 wks | 4.08 | 4.48 | 3.92 |
4 wks | 4.53 | 4.95 | 4.37 |
log2
H1 = A/New Caledonia/20/99; H3 = A/Wisconsin/67/05; B = B Malaysia/2506/4
Inactivated vaccine plus indicated interferon dosage (million units)
Time in relation to vaccination